DE3874378D1 - Aethinylcyclohexenderivate. - Google Patents

Aethinylcyclohexenderivate.

Info

Publication number
DE3874378D1
DE3874378D1 DE8888104437T DE3874378T DE3874378D1 DE 3874378 D1 DE3874378 D1 DE 3874378D1 DE 8888104437 T DE8888104437 T DE 8888104437T DE 3874378 T DE3874378 T DE 3874378T DE 3874378 D1 DE3874378 D1 DE 3874378D1
Authority
DE
Germany
Prior art keywords
formula
compound
image
zeaxanthine
converted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888104437T
Other languages
English (en)
Inventor
Teodor Lukac
Milan Dr Soukup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE3874378D1 publication Critical patent/DE3874378D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
    • C07C35/08—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
    • C07C35/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings with unsaturation only outside the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5435—Cycloaliphatic phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
DE8888104437T 1987-03-27 1988-03-19 Aethinylcyclohexenderivate. Expired - Fee Related DE3874378D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH119187 1987-03-27

Publications (1)

Publication Number Publication Date
DE3874378D1 true DE3874378D1 (en) 1992-10-15

Family

ID=4204633

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888104437T Expired - Fee Related DE3874378D1 (en) 1987-03-27 1988-03-19 Aethinylcyclohexenderivate.

Country Status (6)

Country Link
US (1) US4952716A (de)
EP (1) EP0283979B1 (de)
JP (1) JP2542667B2 (de)
AT (1) ATE80385T1 (de)
DE (1) DE3874378D1 (de)
DK (1) DK171297B1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5625015A (en) 1994-11-23 1997-04-29 Exxon Chemical Patents Inc. Method for making supported catalyst systems and catalyst systems therefrom
DE19509955A1 (de) * 1995-03-18 1996-09-19 Basf Ag Verfahren zur Herstellung von Astaxanthin
JPH11510546A (ja) 1995-08-10 1999-09-14 エクソン・ケミカル・パテンツ・インク メタロセンで安定化されたアルモキサン
US5652202A (en) * 1995-08-15 1997-07-29 Exxon Chemical Patents Inc. Lubricating oil compositions
US5558802A (en) * 1995-09-14 1996-09-24 Exxon Chemical Patents Inc Multigrade crankcase lubricants with low temperature pumpability and low volatility
US5747544A (en) * 1995-10-31 1998-05-05 Applied Food Biotechnology, Inc. Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
US5854015A (en) * 1995-10-31 1998-12-29 Applied Food Biotechnology, Inc. Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
US5827652A (en) * 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
CA2188983C (en) 1995-10-31 2001-02-27 Kevin M. Garnett Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans
DE19723480A1 (de) * 1997-06-04 1998-12-10 Basf Ag Verfahren zur Herstellung von Zeaxanthin, Zwischenprodukte für dieses Verfahren und Verfahren zu deren Herstellung
US7691406B2 (en) * 2000-10-27 2010-04-06 ZeaVision LLC. Zeaxanthin formulations for human ingestion
DE10145223A1 (de) * 2001-09-13 2003-04-03 Basf Ag Verfahren zur Herstellung von meso-Zeaxanthin
US7145025B2 (en) * 2002-07-29 2006-12-05 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
US20070082066A1 (en) * 2003-05-07 2007-04-12 Gierhart Dennis L Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity
US7541166B2 (en) * 2003-09-19 2009-06-02 Microfluidic Systems, Inc. Sonication to selectively lyse different cell types
US7941211B2 (en) * 2003-11-17 2011-05-10 Zeavision, Llc. Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
US20060089411A1 (en) * 2004-08-07 2006-04-27 Gierhart Dennis L Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
US20060183185A1 (en) * 2004-10-01 2006-08-17 Lockwood Samuel F Method for the synthesis of astaxanthin
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
CA2597402A1 (en) * 2005-02-11 2006-08-17 Kalamazoo Holdings, Inc. A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
WO2008003737A1 (de) * 2006-07-07 2008-01-10 Basf Se Verfahren zur herstellung von 3,3'-dihydroxyisorenieratin sowie neue zwischenprodukte hierfür
ES2583004T3 (es) 2010-10-13 2016-09-16 Vigenent Inc. Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1046612B (de) * 1957-10-23 1958-12-18 Basf Ag Verfahren zur Herstellung von Vitamin A und seinen biologisch wirksamen Derivaten
BE754225A (fr) * 1969-08-01 1971-02-01 Hoffmann La Roche Procede pour la preparation de derives polyeniques
US4153615A (en) * 1978-03-27 1979-05-08 Hoffmann-La Roche Inc. Method of producing coloring agents
EP0100839B1 (de) * 1982-07-16 1986-05-07 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Katalytische Hydrierung acetylenischer Phosphoniumsalze
DE3476381D1 (en) * 1983-03-25 1989-03-02 Hoffmann La Roche Process for the preparation of pentadienol derivatives

Also Published As

Publication number Publication date
JP2542667B2 (ja) 1996-10-09
DK106388A (da) 1988-09-28
EP0283979A2 (de) 1988-09-28
DK171297B1 (da) 1996-08-26
US4952716A (en) 1990-08-28
JPS63264565A (ja) 1988-11-01
ATE80385T1 (de) 1992-09-15
DK106388D0 (da) 1988-02-29
EP0283979A3 (en) 1988-12-07
EP0283979B1 (de) 1992-09-09

Similar Documents

Publication Publication Date Title
DE3874378D1 (en) Aethinylcyclohexenderivate.
KR870010071A (ko) 1-데옥시노지리마이신 및 그의 n-유도체의 제조방법
JPS55149307A (en) Ethylene polymerizing method
CA2188181A1 (en) Preparation of purines
EP0248195A3 (de) Herstellungsverfahren von Aluminiumalkoxyd oder Aluminiumaryloxyd
EP0376145A3 (de) Verfahren zur Herstellung von stereoregularem Polyolefin
PT71528B (en) Process for preparing acetyl acetoxyalkyl-allyl ethers useful for the polymerization of vinyl compounds
KR880005145A (ko) N-글리코릴네우라민산 함유 당지질 및 그 제조방법
CA1245226A (en) METHOD FOR THE PREPARATION OF HMG-COA REDUCTASE INHIBITORS AND INTERMEDIATE COMPOUNDS
ATE156134T1 (de) Verfahren zur herstellung von alkylpolyglukosiden
GB2087389B (en) Preparation of monoalkylethers of hudroquinone or substituted hydroquinones
EP0240431A3 (en) Process for the preparation of ethylenic carbonyl compounds
KR910006288A (ko) 신규 제조방법
KR920002508A (ko) 2,4-디히드록시아디프산 유도체
GB2001990A (en) Preparation of 16 alpha -methyl- prednisolone and derivatives thereof via 17 alpha -hydroperoxy analogues
KR910007945A (ko) 알킬 메틸-3-카브알콕시에틸포스피네이트의 제조방법
CA2038011A1 (en) Processes for Preparing 2-Halogeno-3-Hydroxy-3-Phenyl-Propionic Acid Ester Compounds
HUT59146A (en) Process for transforming delta above 16 steroids into delta above 17(20)-20-silylethers
CA2006758A1 (en) Method for preparing catalyst precursor for methanol synthesis
DE3360788D1 (en) Process for the preparation of 3-methyl-3-hydroxyglutaric acid and an intermediate product for the preparation thereof
PL244352A1 (en) Process for preparing penicillanoyloxymethyl-6-beta-aminopenicillinate 1,1-dioxide
CA2099576A1 (en) Process for Producing 2-(Dialkyloxy Methyl)-Carboxyli c Acid Esters
GB1455910A (en) Process for the preparation of 1alpha-hydroxycholecalciferol and intermediate for use in said process
KR840002842A (ko) 2-페닐이미다조[2,1-b] 벤조티아졸 화합물의 제조방법
KR890005114A (ko) 마크롤리드 화합물의 제조 방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee